Background Serum PSA is an important tumor marker for diagnosis of prostate cancer. However, it can rise in some other benign conditions like benign prostatic hyperplasia (BPH), prostatitis, prostatic infarct, instrumentation, prostate manipulations like examination, transurethral resection and urinary tract infection (UTI).
Binita Goyal, Alina Baral
openaire +1 more source
Purpose: To validate the use of estimated post-enucleation prostate-specific antigen (EPEPSA) and extra-transitional zone density (EtzD) in predicting clinically significant prostate cancer (csPC) in a Taiwanese cohort.
Jung-Yang Yu +5 more
doaj +1 more source
Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging. [PDF]
Lin YT +4 more
europepmc +1 more source
Prostate-specific antigen density as the best predictor of low- to intermediate-risk prostate cancer: a cohort study. [PDF]
Park DH, Yu JH.
europepmc +1 more source
INTEGRATING PROSTATE SPECIFIC ANTIGEN DENSITY BIOMARKER INTO DEEP LEARNING PROSTATE MRI LESION SEGMENTATION MODELS. [PDF]
Zhong J +3 more
europepmc +1 more source
Quantitative Evaluation of Apparent Diffusion Coefficient Values, ISUP Grades and Prostate-Specific Antigen Density Values of Potentially Malignant PI-RADS Lesions. [PDF]
Spadarotto N +5 more
europepmc +1 more source
Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer. [PDF]
Yang CK +13 more
europepmc +1 more source
Multiparametric Magnetic Resonance Imaging-based Prostate Specific Antigen Density and PI-RADSv2 score help identify Apical Prostate Cancer. [PDF]
Huang C +7 more
europepmc +1 more source
Phenotypic and functional differences of dendritic cells generated under different in vitro conditions [PDF]
Ali, SA +4 more
core +1 more source
PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone. [PDF]
Wen J, Tang T, Ji Y, Zhang Y.
europepmc +1 more source

